Dyslipidemia in chronic kidney disease: Causes and consequences

Cardiovascular risk increases with each decrement in renal function. Abnormalities in plasma lipoprotein composition among patients with end-stage renal disease represent a change both in lipoprotein level and structure. Low-density lipoprotein (LDL) cholesterol is not increased and LDL level is not...

Full description

Saved in:
Bibliographic Details
Published inKidney international Vol. 70; no. S104; pp. S55 - S58
Main Author Kaysen, G.A.
Format Journal Article
LanguageEnglish
Published London Elsevier Inc 01.12.2006
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cardiovascular risk increases with each decrement in renal function. Abnormalities in plasma lipoprotein composition among patients with end-stage renal disease represent a change both in lipoprotein level and structure. Low-density lipoprotein (LDL) cholesterol is not increased and LDL level is not strongly correlated with outcome. In contrast, high-density lipoprotein (HDL) levels are decreased and are inversely associated with cardiovascular risk. HDL is decreased because of an increased rate of catabolism associated with a predominance of small dense HDL. HDL fails to mature normally as a result of decreased lecithin cholesterol ester (CE) transfer protein (lecithin:cholesterol acyltransferase), leaving CE poor, triglyceride (TG) rich HDL3, and pre β HDL. Chronic kidney disease (CKD) also causes insulin resistance, and this may also contribute to low HDL levels. Plasma TG levels are increased and TGs are found in an expanded intermediate density lipoprotein (IDL) pool. These are composed of chylomicron and very low-density lipoprotein remnants resulting from delayed lipolysis on the endothelium and impaired hepatic uptake. IDL in contrast to LDL is associated with vascular disease in dialysis patients. Lipoprotein (a) (Lp (a)) levels are also increased. In patients without renal disease. The concentration of Lp (a) is inversely associated with the size of the apolipoprotein (a) isoform inherited; Lp (a) levels are increased in patients with kidney disease as a consequence of increased concentrations, primarily of the high molecular weight isoform. Lp (a) levels are also associated with cardiovascular outcome among dialysis patients.
AbstractList Cardiovascular risk increases with each decrement in renal function. Abnormalities in plasma lipoprotein composition among patients with end-stage renal disease represent a change both in lipoprotein level and structure. Low-density lipoprotein (LDL) cholesterol is not increased and LDL level is not strongly correlated with outcome. In contrast, high-density lipoprotein (HDL) levels are decreased and are inversely associated with cardiovascular risk. HDL is decreased because of an increased rate of catabolism associated with a predominance of small dense HDL. HDL fails to mature normally as a result of decreased lecithin cholesterol ester (CE) transfer protein (lecithin:cholesterol acyltransferase), leaving CE poor, triglyceride (TG) rich HDL3, and pre β HDL. Chronic kidney disease (CKD) also causes insulin resistance, and this may also contribute to low HDL levels. Plasma TG levels are increased and TGs are found in an expanded intermediate density lipoprotein (IDL) pool. These are composed of chylomicron and very low-density lipoprotein remnants resulting from delayed lipolysis on the endothelium and impaired hepatic uptake. IDL in contrast to LDL is associated with vascular disease in dialysis patients. Lipoprotein (a) (Lp (a)) levels are also increased. In patients without renal disease. The concentration of Lp (a) is inversely associated with the size of the apolipoprotein (a) isoform inherited; Lp (a) levels are increased in patients with kidney disease as a consequence of increased concentrations, primarily of the high molecular weight isoform. Lp (a) levels are also associated with cardiovascular outcome among dialysis patients.Kidney International (2006) 70, S55-S58. doi:10.1038/sj.ki.5001979
Cardiovascular risk increases with each decrement in renal function. Abnormalities in plasma lipoprotein composition among patients with end-stage renal disease represent a change both in lipoprotein level and structure. Low-density lipoprotein (LDL) cholesterol is not increased and LDL level is not strongly correlated with outcome. In contrast, high-density lipoprotein (HDL) levels are decreased and are inversely associated with cardiovascular risk. HDL is decreased because of an increased rate of catabolism associated with a predominance of small dense HDL. HDL fails to mature normally as a result of decreased lecithin cholesterol ester (CE) transfer protein (lecithin:cholesterol acyltransferase), leaving CE poor, triglyceride (TG) rich HDL3, and pre β HDL. Chronic kidney disease (CKD) also causes insulin resistance, and this may also contribute to low HDL levels. Plasma TG levels are increased and TGs are found in an expanded intermediate density lipoprotein (IDL) pool. These are composed of chylomicron and very low-density lipoprotein remnants resulting from delayed lipolysis on the endothelium and impaired hepatic uptake. IDL in contrast to LDL is associated with vascular disease in dialysis patients. Lipoprotein (a) (Lp (a)) levels are also increased. In patients without renal disease. The concentration of Lp (a) is inversely associated with the size of the apolipoprotein (a) isoform inherited; Lp (a) levels are increased in patients with kidney disease as a consequence of increased concentrations, primarily of the high molecular weight isoform. Lp (a) levels are also associated with cardiovascular outcome among dialysis patients.
Author Kaysen, G.A.
Author_xml – sequence: 1
  givenname: G.A.
  surname: Kaysen
  fullname: Kaysen, G.A.
  email: gakaysen@ucdavis.edu
  organization: Division of Nephrology, Department of Medicine, Davis, California, USA
BookMark eNp1kM1Lw0AQxRdRsK0ePQrBe-puNptkvYjUTyh40fOyzk5w03ZTdxKh_70pKXryNAzvx3u8N2XHoQ3I2IXgc8FldU3NfOXninOhS33EJkJlMhWlUsdswnml0kzJ6pRNiRo-_FryCbu939Hab73DjbeJDwl8xjZ4SFbeBdwlzhNawptkYXtCSmxwCbSB8KvHAEhn7KS2a8Lzw52x98eHt8Vzunx9elncLVOQpexSzG2d5RrgA7BwRZnrUklllUCXZ1mOGl0tQFcFSMjr2oGDTBYl1jlIOyhyxq5G321sh2jqTNP2MQyRJhNcFJorPkDpCEFsiSLWZhv9xsadEdzsJzLUmJU3h4kG_nLkg-36iL_0n16OOg7Nvj1GQ-D3tZ2PCJ1xrf_H-QdH53lW
CitedBy_id crossref_primary_10_1038_srep22151
crossref_primary_10_1007_s00467_020_04545_z
crossref_primary_10_1038_nrneph_2015_173
crossref_primary_10_1016_j_atherosclerosis_2014_02_006
crossref_primary_10_1186_s12944_024_02050_y
crossref_primary_10_18087_cardio_2611
crossref_primary_10_20960_nh_03921
crossref_primary_10_1021_acs_jproteome_6b00170
crossref_primary_10_1053_j_ackd_2015_12_004
crossref_primary_10_1186_1475_2840_6_37
crossref_primary_10_1007_s00467_023_06144_0
crossref_primary_10_1016_j_clinbiochem_2007_07_007
crossref_primary_10_1186_1471_2458_12_712
crossref_primary_10_1053_j_ajkd_2008_05_027
crossref_primary_10_1016_j_cbi_2021_109427
crossref_primary_10_3390_ijms21072632
crossref_primary_10_1007_s11255_008_9497_6
crossref_primary_10_1038_sj_ki_5001967
crossref_primary_10_1007_s10157_019_01776_9
crossref_primary_10_1080_09674845_2012_12069133
crossref_primary_10_1681_ASN_2011070668
crossref_primary_10_1681_ASN_2020091376
crossref_primary_10_3390_ijms21217994
crossref_primary_10_1186_s12889_019_7328_6
Cites_doi 10.1046/j.1523-1755.2003.00019.x
10.1038/oby.2005.118
10.5551/jat.10.283
10.1016/S0272-6386(00)70255-1
10.1097/01.ASN.0000117286.85443.7D
10.1073/pnas.82.23.8242
10.1152/ajprenal.00099.2005
10.1038/ki.1997.260
10.1056/NEJMoa043545
10.1161/01.ATV.0000137975.14996.df
10.2337/diabetes.47.12.1928
10.1074/jbc.270.45.26910
10.1097/00041433-200004000-00005
10.1016/0009-8981(82)90386-2
10.1681/ASN.V111105
10.1046/j.1523-1755.2002.00324.x
10.1681/ASN.V971277
10.1093/ndt/12.12.2603
10.1016/S0939-4753(03)80011-X
10.1681/ASN.2004110922
10.1097/01.ASN.0000046962.43220.8A
10.1681/ASN.V981474
10.1016/S0021-9150(99)00150-1
10.1053/j.ajkd.2004.09.034
10.1002/1520-7560(200007/08)16:4<237::AID-DMRR127>3.0.CO;2-9
10.1056/NEJMoa041031
10.1016/0021-9150(89)90075-0
ContentType Journal Article
Copyright 2006 International Society of Nephrology
Copyright Nature Publishing Group Dec 2006
Copyright_xml – notice: 2006 International Society of Nephrology
– notice: Copyright Nature Publishing Group Dec 2006
DBID 6I.
AAFTH
AAYXX
CITATION
3V.
7QP
7RV
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
DOI 10.1038/sj.ki.5001979
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
ProQuest Nursing and Allied Health Journals
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DatabaseTitle CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
DatabaseTitleList ProQuest One Academic Eastern Edition

Database_xml – sequence: 1
  dbid: 7X7
  name: ProQuest Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1523-1755
EndPage S58
ExternalDocumentID 1163301841
10_1038_sj_ki_5001979
5001979
S0085253815518590
GroupedDBID ---
.55
.GJ
0R~
1CY
29L
2WC
36B
39C
3O-
3V.
4.4
457
53G
5GY
5RE
5VS
6I.
6PF
7RV
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACTN
AAEDW
AAFTH
AAIAV
AAKUH
AALRI
AAQFI
AAWTL
AAXUO
ABAWZ
ABJNI
ABLJU
ABMAC
ABOCM
ABUWG
ABVKL
ACGFO
ACGFS
ACPRK
ADBBV
ADEZE
ADFRT
ADQMX
AENEX
AEXQZ
AFEBI
AFKRA
AFTJW
AGHFR
AHMBA
AHPSJ
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BENPR
BFHJK
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DU5
EBS
EJD
EX3
F5P
FDB
FRP
FYUFA
GX1
HMCUK
HZ~
IHE
J5H
JSO
KQ8
L7B
LH4
LW6
M1P
M41
MJL
N4W
NAPCQ
NCXOZ
O9-
OK1
P2P
P6G
PQQKQ
PROAC
PSQYO
Q2X
R9-
RIG
RNS
ROL
SDH
SSZ
TR2
UKHRP
W2D
WOW
X7M
XVB
YFH
YOC
YUY
ZA5
ZCG
ZGI
ZXP
-
08R
0R
55
ABFLS
ABPTK
ADBIT
AFETI
BBAFP
GJ
HZ
IPNFZ
PQEST
PQUKI
PRINS
XIP
0SF
AAYXX
ADVLN
AFJKZ
AKRWK
ALIPV
CITATION
7QP
7XB
8FK
K9.
ID FETCH-LOGICAL-c373t-e4af249ccbce6d67497535a51ed4224e9edf1c986c3c4ffdcdc2367ef4c3af1c3
IEDL.DBID ABVKL
ISSN 0085-2538
IngestDate Thu Oct 10 19:55:49 EDT 2024
Thu Sep 26 17:34:22 EDT 2024
Thu Oct 07 19:33:43 EDT 2021
Fri Feb 23 02:28:08 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue S104
Keywords IDL
CETP
LCAT
apo A I
apo C III
hepatic lipase
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c373t-e4af249ccbce6d67497535a51ed4224e9edf1c986c3c4ffdcdc2367ef4c3af1c3
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0085253815518590
PQID 210169050
PQPubID 47198
ParticipantIDs proquest_journals_210169050
crossref_primary_10_1038_sj_ki_5001979
nature_primary_5001979
elsevier_sciencedirect_doi_10_1038_sj_ki_5001979
ProviderPackageCode ADQMX
PublicationCentury 2000
PublicationDate 2006-12-01
PublicationDateYYYYMMDD 2006-12-01
PublicationDate_xml – month: 12
  year: 2006
  text: 2006-12-01
  day: 01
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Kidney international
PublicationYear 2006
Publisher Elsevier Inc
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
References Elshourbagy, Boguski, Liao (bb0080) 1985; 82
Koch, Kutkuhn, Grabensee, Ritz (bb0060) 1997; 12
Welty, Lichtenstein, Barrett (bb0065) 2004; 24
Pietzsch, Julius, Nitzsche, Hanefeld (bb0100) 1998; 47
Rye, Clay, Barter (bb0110) 1999; 145
Deighan, Caslake, McConnell (bb0030) 2000; 35
Shoji, Nishizawa, Kawagishi (bb0055) 1998; 9
Mendez, Perez, Hsia (bb0115) 1988; 111
Mekki, Bouchenak, Remaoun, Belleville (bb0120) 2004; 10
Go, Chertow, Fan (bb0015) 2004; 351
USRDS (bb0010) 2005
Quintao, Medina, Passarelli (bb0085) 2000; 16
Ooi, Watts, Farvid (bb0105) 2005; 13
Hunsicker, Adler, Caggiula (bb0075) 1997; 51
Wanner, Krane, Marz (bb0025) 2005; 353
Hirano, Sakaue, Misaki (bb0035) 2003; 63
Okubo, Ikewaki, Sakai (bb0040) 2004; 15
Moestrup, Kozyraki (bb0095) 2000; 11
Sparks, Davidson, Lund-Katz, Phillips (bb0090) 1995; 270
De Sain-Van Der Velden, Reijngoud, Kaysen (bb0145) 1998; 9
Espino-Montoro, Barrios-Artillo, Lopez-Chozas (bb0130) 2003; 13
Kuboyama, Ageta, Ishihara (bb0150) 2003; 10
Kobayashi, Maesato, Moriya (bb0070) 2005; 45
Iseki, Yamazato, Tozawa, Takishita (bb0020) 2002; 61
Longenecker, Klag, Marcovina (bb0155) 2005; 16
Malmendier, Lontie, Delcroix (bb0135) 1989; 77
Vaziri (bb0050) 2006; 290
Kronenberg, Kuen, Ritz (bb0140) 2000; 11
Miida, Miyazaki, Hanyu (bb0045) 2003; 14
Chan, Ramdial, Varghese (bb0125) 1982; 124
Mekki, K, Bouchenak, M, Remaoun, M, Belleville, JL 2004; 10
Chan, MK, Ramdial, L, Varghese, Z 1982; 124
Kuboyama, M, Ageta, M, Ishihara, T 2003; 10
Vaziri, ND 2006; 290
Moestrup, SK, Kozyraki, R 2000; 11
Welty, FK, Lichtenstein, AH, Barrett, PH 2004; 24
Longenecker, JC, Klag, MJ, Marcovina, SM 2005; 16
Iseki, K, Yamazato, M, Tozawa, M, Takishita, S 2002; 61
Miida, T, Miyazaki, O, Hanyu, O 2003; 14
De Sain-Van Der Velden, MG, Reijngoud, DJ, Kaysen, GA 1998; 9
2005
Pietzsch, J, Julius, U, Nitzsche, S, Hanefeld, M 1998; 47
Malmendier, CL, Lontie, JF, Delcroix, C 1989; 77
Hunsicker, LG, Adler, S, Caggiula, A 1997; 51
Sparks, DL, Davidson, WS, Lund-Katz, S, Phillips, MC 1995; 270
Okubo, K, Ikewaki, K, Sakai, S 2004; 15
Quintao, EC, Medina, WL, Passarelli, M 2000; 16
Deighan, CJ, Caslake, MJ, McConnell, M 2000; 35
Wanner, C, Krane, V, Marz, W 2005; 353
Mendez, AJ, Perez, GO, Hsia, SL 1988; 111
Ooi, EM, Watts, GF, Farvid, MS 2005; 13
Rye, KA, Clay, MA, Barter, PJ 1999; 145
Go, AS, Chertow, GM, Fan, D 2004; 351
Hirano, T, Sakaue, T, Misaki, A 2003; 63
Shoji, T, Nishizawa, Y, Kawagishi, T 1998; 9
Koch, M, Kutkuhn, B, Grabensee, B, Ritz, E 1997; 12
Espino-Montoro, A, Barrios-Artillo, M, Lopez-Chozas, JM 2003; 13
Elshourbagy, NA, Boguski, MS, Liao, WS 1985; 82
Kobayashi, S, Maesato, K, Moriya, H 2005; 45
Kronenberg, F, Kuen, E, Ritz, E 2000; 11
Longenecker (10.1038/sj.ki.5001979_bb0155) 2005; 16
Iseki (10.1038/sj.ki.5001979_bb0020) 2002; 61
Mendez (10.1038/sj.ki.5001979_bb0115) 1988; 111
Mekki (10.1038/sj.ki.5001979_bb0120) 2004; 10
Koch (10.1038/sj.ki.5001979_bb0060) 1997; 12
Vaziri (10.1038/sj.ki.5001979_bb0050) 2006; 290
Wanner (10.1038/sj.ki.5001979_bb0025) 2005; 353
Espino-Montoro (10.1038/sj.ki.5001979_bb0130) 2003; 13
Hunsicker (10.1038/sj.ki.5001979_bb0075) 1997; 51
Moestrup (10.1038/sj.ki.5001979_bb0095) 2000; 11
Elshourbagy (10.1038/sj.ki.5001979_bb0080) 1985; 82
Chan (10.1038/sj.ki.5001979_bb0125) 1982; 124
Miida (10.1038/sj.ki.5001979_bb0045) 2003; 14
Ooi (10.1038/sj.ki.5001979_bb0105) 2005; 13
Kuboyama (10.1038/sj.ki.5001979_bb0150) 2003; 10
Kronenberg (10.1038/sj.ki.5001979_bb0140) 2000; 11
Go (10.1038/sj.ki.5001979_bb0015) 2004; 351
Pietzsch (10.1038/sj.ki.5001979_bb0100) 1998; 47
Quintao (10.1038/sj.ki.5001979_bb0085) 2000; 16
Kobayashi (10.1038/sj.ki.5001979_bb0070) 2005; 45
De Sain-Van Der Velden (10.1038/sj.ki.5001979_bb0145) 1998; 9
Malmendier (10.1038/sj.ki.5001979_bb0135) 1989; 77
Rye (10.1038/sj.ki.5001979_bb0110) 1999; 145
Hirano (10.1038/sj.ki.5001979_bb0035) 2003; 63
Okubo (10.1038/sj.ki.5001979_bb0040) 2004; 15
Deighan (10.1038/sj.ki.5001979_bb0030) 2000; 35
Shoji (10.1038/sj.ki.5001979_bb0055) 1998; 9
USRDS (10.1038/sj.ki.5001979_bb0010) 2005
Sparks (10.1038/sj.ki.5001979_bb0090) 1995; 270
Welty (10.1038/sj.ki.5001979_bb0065) 2004; 24
References_xml – volume: 63
  start-page: 2171
  year: 2003
  end-page: 2177
  ident: bb0035
  article-title: Very low-density lipoprotein-apoprotein C I is increased in diabetic nephropathy: comparison with apoprotein CIII
  publication-title: Kidney Int
  contributor:
    fullname: Misaki
– volume: 9
  start-page: 1474
  year: 1998
  end-page: 1481
  ident: bb0145
  article-title: Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Kaysen
– volume: 16
  start-page: 1794
  year: 2005
  end-page: 1802
  ident: bb0155
  article-title: High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Marcovina
– volume: 61
  start-page: 1887
  year: 2002
  end-page: 1893
  ident: bb0020
  article-title: Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients
  publication-title: Kidney Int
  contributor:
    fullname: Takishita
– volume: 82
  start-page: 8242
  year: 1985
  end-page: 8246
  ident: bb0080
  article-title: Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Liao
– volume: 11
  start-page: 105
  year: 2000
  end-page: 115
  ident: bb0140
  article-title: Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Ritz
– volume: 290
  start-page: F262
  year: 2006
  end-page: F272
  ident: bb0050
  article-title: Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
  publication-title: Am J Physiol Renal Physiol
  contributor:
    fullname: Vaziri
– volume: 351
  start-page: 1296
  year: 2004
  end-page: 1305
  ident: bb0015
  article-title: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
  publication-title: N Engl J Med
  contributor:
    fullname: Fan
– volume: 16
  start-page: 237
  year: 2000
  end-page: 250
  ident: bb0085
  article-title: Related Reverse cholesterol transport in diabetes mellitus
  publication-title: Diabetes Metab Res Rev
  contributor:
    fullname: Passarelli
– start-page: 128
  year: 2005
  end-page: 129
  ident: bb0010
  publication-title: 17th Annual Report NIH/NIDDK/Division of Kidney, Urologic & Hematologic Diseases Annual
  contributor:
    fullname: USRDS
– volume: 47
  start-page: 1928
  year: 1998
  end-page: 1934
  ident: bb0100
  article-title: evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance
  publication-title: Diabetes
  contributor:
    fullname: Hanefeld
– volume: 45
  start-page: 275
  year: 2005
  end-page: 280
  ident: bb0070
  article-title: Insulin resistance in patients with chronic kidney disease
  publication-title: Am J Kidney Dis
  contributor:
    fullname: Moriya
– volume: 51
  start-page: 1908
  year: 1997
  end-page: 1919
  ident: bb0075
  article-title: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
  publication-title: Kidney Int
  contributor:
    fullname: Caggiula
– volume: 145
  start-page: 227
  year: 1999
  end-page: 238
  ident: bb0110
  article-title: Remodelling of high density lipoproteins by plasma factors
  publication-title: Atherosclerosis
  contributor:
    fullname: Barter
– volume: 353
  start-page: 238
  year: 2005
  end-page: 248
  ident: bb0025
  article-title: German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
  publication-title: N Engl J Med
  contributor:
    fullname: Marz
– volume: 13
  start-page: 1008
  year: 2005
  end-page: 1016
  ident: bb0105
  article-title: High-density lipoprotein apolipoprotein A-I kinetics in obesity
  publication-title: Obes Res
  contributor:
    fullname: Farvid
– volume: 10
  start-page: 283
  year: 2003
  end-page: 289
  ident: bb0150
  article-title: Serum lipoprotein(a) concentration and Apo(a) isoform under the condition of renal dysfunction
  publication-title: J Atheroscler Thromb
  contributor:
    fullname: Ishihara
– volume: 124
  start-page: 187
  year: 1982
  end-page: 193
  ident: bb0125
  article-title: Plasma LCAT activities in renal allograft recipients
  publication-title: Clin Chim Acta
  contributor:
    fullname: Varghese
– volume: 11
  start-page: 133
  year: 2000
  end-page: 140
  ident: bb0095
  article-title: Cubilin, a high-density lipoprotein receptor
  publication-title: Curr Opin Lipidol
  contributor:
    fullname: Kozyraki
– volume: 77
  start-page: 139
  year: 1989
  end-page: 149
  ident: bb0135
  article-title: Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration
  publication-title: Atherosclerosis
  contributor:
    fullname: Delcroix
– volume: 12
  start-page: 2603
  year: 1997
  end-page: 2611
  ident: bb0060
  article-title: Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects
  publication-title: Nephrol Dial Transplant
  contributor:
    fullname: Ritz
– volume: 270
  start-page: 26910
  year: 1995
  end-page: 26917
  ident: bb0090
  article-title: Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability
  publication-title: J Biol Chem
  contributor:
    fullname: Phillips
– volume: 13
  start-page: 194
  year: 2003
  end-page: 201
  ident: bb0130
  article-title: Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism
  publication-title: Nutr Metab Cardiovasc Dis
  contributor:
    fullname: Lopez-Chozas
– volume: 15
  start-page: 1008
  year: 2004
  end-page: 1015
  ident: bb0040
  article-title: Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Sakai
– volume: 14
  start-page: 732
  year: 2003
  end-page: 738
  ident: bb0045
  article-title: LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Hanyu
– volume: 9
  start-page: 1277
  year: 1998
  end-page: 1284
  ident: bb0055
  article-title: Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Kawagishi
– volume: 24
  start-page: 1703
  year: 2004
  end-page: 1707
  ident: bb0065
  article-title: Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes
  publication-title: Arterioscler Thromb Vasc Biol
  contributor:
    fullname: Barrett
– volume: 35
  start-page: 852
  year: 2000
  end-page: 862
  ident: bb0030
  article-title: Related atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation
  publication-title: Am J Kidney Dis
  contributor:
    fullname: McConnell
– volume: 10
  start-page: CR439
  year: 2004
  end-page: CR446
  ident: bb0120
  article-title: Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study
  publication-title: Med Sci Monit
  contributor:
    fullname: Belleville
– volume: 111
  start-page: 677
  year: 1988
  end-page: 683
  ident: bb0115
  article-title: Defect in cholesteryl ester transport in serum of patients with uremia receiving maintenance hemodialysis: increased inhibitor activity for cholesteryl ester transfer
  publication-title: J Lab Clin Med
  contributor:
    fullname: Hsia
– volume: 35
  start-page: 852
  year: 2000
  end-page: 862
  article-title: Related atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation
  publication-title: Am J Kidney Dis
  contributor:
    fullname: McConnell, M
– volume: 290
  start-page: F262
  year: 2006
  end-page: F272
  article-title: Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
  publication-title: Am J Physiol Renal Physiol
  contributor:
    fullname: Vaziri, ND
– volume: 9
  start-page: 1277
  year: 1998
  end-page: 1284
  article-title: Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Kawagishi, T
– volume: 24
  start-page: 1703
  year: 2004
  end-page: 1707
  article-title: Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes
  publication-title: Arterioscler Thromb Vasc Biol
  contributor:
    fullname: Barrett, PH
– volume: 16
  start-page: 237
  year: 2000
  end-page: 250
  article-title: Related Reverse cholesterol transport in diabetes mellitus
  publication-title: Diabetes Metab Res Rev
  contributor:
    fullname: Passarelli, M
– volume: 82
  start-page: 8242
  year: 1985
  end-page: 8246
  article-title: Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Liao, WS
– volume: 14
  start-page: 732
  year: 2003
  end-page: 738
  article-title: LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Hanyu, O
– volume: 13
  start-page: 194
  year: 2003
  end-page: 201
  article-title: Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism
  publication-title: Nutr Metab Cardiovasc Dis
  contributor:
    fullname: Lopez-Chozas, JM
– volume: 11
  start-page: 133
  year: 2000
  end-page: 140
  article-title: Cubilin, a high-density lipoprotein receptor
  publication-title: Curr Opin Lipidol
  contributor:
    fullname: Kozyraki, R
– volume: 270
  start-page: 26910
  year: 1995
  end-page: 26917
  article-title: Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability
  publication-title: J Biol Chem
  contributor:
    fullname: Phillips, MC
– volume: 16
  start-page: 1794
  year: 2005
  end-page: 1802
  article-title: High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Marcovina, SM
– volume: 45
  start-page: 275
  year: 2005
  end-page: 280
  article-title: Insulin resistance in patients with chronic kidney disease
  publication-title: Am J Kidney Dis
  contributor:
    fullname: Moriya, H
– start-page: 128
  year: 2005
  end-page: 129
  publication-title: 17th Annual Report NIH NIDDK Division of Kidney, Urologic & Hematologic Diseases Annual
– volume: 12
  start-page: 2603
  year: 1997
  end-page: 2611
  article-title: Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects
  publication-title: Nephrol Dial Transplant
  contributor:
    fullname: Ritz, E
– volume: 77
  start-page: 139
  year: 1989
  end-page: 149
  article-title: Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration
  publication-title: Atherosclerosis
  contributor:
    fullname: Delcroix, C
– volume: 145
  start-page: 227
  year: 1999
  end-page: 238
  article-title: Remodelling of high density lipoproteins by plasma factors
  publication-title: Atherosclerosis
  contributor:
    fullname: Barter, PJ
– volume: 47
  start-page: 1928
  year: 1998
  end-page: 1934
  article-title: evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance
  publication-title: Diabetes
  contributor:
    fullname: Hanefeld, M
– volume: 13
  start-page: 1008
  year: 2005
  end-page: 1016
  article-title: High-density lipoprotein apolipoprotein A-I kinetics in obesity
  publication-title: Obes Res
  contributor:
    fullname: Farvid, MS
– volume: 15
  start-page: 1008
  year: 2004
  end-page: 1015
  article-title: Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Sakai, S
– volume: 61
  start-page: 1887
  year: 2002
  end-page: 1893
  article-title: Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients
  publication-title: Kidney Int
  contributor:
    fullname: Takishita, S
– volume: 63
  start-page: 2171
  year: 2003
  end-page: 2177
  article-title: Very low-density lipoprotein-apoprotein C I is increased in diabetic nephropathy: comparison with apoprotein CIII
  publication-title: Kidney Int
  contributor:
    fullname: Misaki, A
– volume: 9
  start-page: 1474
  year: 1998
  end-page: 1481
  article-title: Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Kaysen, GA
– volume: 11
  start-page: 105
  year: 2000
  end-page: 115
  article-title: Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Ritz, E
– volume: 351
  start-page: 1296
  year: 2004
  end-page: 1305
  article-title: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
  publication-title: N Engl J Med
  contributor:
    fullname: Fan, D
– volume: 353
  start-page: 238
  year: 2005
  end-page: 248
  article-title: German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
  publication-title: N Engl J Med
  contributor:
    fullname: Marz, W
– volume: 51
  start-page: 1908
  year: 1997
  end-page: 1919
  article-title: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
  publication-title: Kidney Int
  contributor:
    fullname: Caggiula, A
– volume: 111
  start-page: 677
  year: 1988
  end-page: 683
  article-title: Defect in cholesteryl ester transport in serum of patients with uremia receiving maintenance hemodialysis: increased inhibitor activity for cholesteryl ester transfer
  publication-title: J Lab Clin Med
  contributor:
    fullname: Hsia, SL
– volume: 10
  start-page: CR439
  year: 2004
  end-page: CR446
  article-title: Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study
  publication-title: Med Sci Monit
  contributor:
    fullname: Belleville, JL
– volume: 10
  start-page: 283
  year: 2003
  end-page: 289
  article-title: Serum lipoprotein(a) concentration and Apo(a) isoform under the condition of renal dysfunction
  publication-title: J Atheroscler Thromb
  contributor:
    fullname: Ishihara, T
– volume: 124
  start-page: 187
  year: 1982
  end-page: 193
  article-title: Plasma LCAT activities in renal allograft recipients
  publication-title: Clin Chim Acta
  contributor:
    fullname: Varghese, Z
– volume: 63
  start-page: 2171
  year: 2003
  ident: 10.1038/sj.ki.5001979_bb0035
  article-title: Very low-density lipoprotein-apoprotein C I is increased in diabetic nephropathy: comparison with apoprotein CIII
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2003.00019.x
  contributor:
    fullname: Hirano
– volume: 13
  start-page: 1008
  year: 2005
  ident: 10.1038/sj.ki.5001979_bb0105
  article-title: High-density lipoprotein apolipoprotein A-I kinetics in obesity
  publication-title: Obes Res
  doi: 10.1038/oby.2005.118
  contributor:
    fullname: Ooi
– volume: 10
  start-page: 283
  year: 2003
  ident: 10.1038/sj.ki.5001979_bb0150
  article-title: Serum lipoprotein(a) concentration and Apo(a) isoform under the condition of renal dysfunction
  publication-title: J Atheroscler Thromb
  doi: 10.5551/jat.10.283
  contributor:
    fullname: Kuboyama
– volume: 35
  start-page: 852
  year: 2000
  ident: 10.1038/sj.ki.5001979_bb0030
  article-title: Related atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation
  publication-title: Am J Kidney Dis
  doi: 10.1016/S0272-6386(00)70255-1
  contributor:
    fullname: Deighan
– volume: 15
  start-page: 1008
  year: 2004
  ident: 10.1038/sj.ki.5001979_bb0040
  article-title: Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000117286.85443.7D
  contributor:
    fullname: Okubo
– volume: 82
  start-page: 8242
  year: 1985
  ident: 10.1038/sj.ki.5001979_bb0080
  article-title: Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.82.23.8242
  contributor:
    fullname: Elshourbagy
– start-page: 128
  year: 2005
  ident: 10.1038/sj.ki.5001979_bb0010
  contributor:
    fullname: USRDS
– volume: 290
  start-page: F262
  year: 2006
  ident: 10.1038/sj.ki.5001979_bb0050
  article-title: Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00099.2005
  contributor:
    fullname: Vaziri
– volume: 51
  start-page: 1908
  year: 1997
  ident: 10.1038/sj.ki.5001979_bb0075
  article-title: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
  publication-title: Kidney Int
  doi: 10.1038/ki.1997.260
  contributor:
    fullname: Hunsicker
– volume: 353
  start-page: 238
  year: 2005
  ident: 10.1038/sj.ki.5001979_bb0025
  article-title: German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa043545
  contributor:
    fullname: Wanner
– volume: 24
  start-page: 1703
  year: 2004
  ident: 10.1038/sj.ki.5001979_bb0065
  article-title: Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000137975.14996.df
  contributor:
    fullname: Welty
– volume: 47
  start-page: 1928
  year: 1998
  ident: 10.1038/sj.ki.5001979_bb0100
  article-title: In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance
  publication-title: Diabetes
  doi: 10.2337/diabetes.47.12.1928
  contributor:
    fullname: Pietzsch
– volume: 270
  start-page: 26910
  year: 1995
  ident: 10.1038/sj.ki.5001979_bb0090
  article-title: Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.45.26910
  contributor:
    fullname: Sparks
– volume: 11
  start-page: 133
  year: 2000
  ident: 10.1038/sj.ki.5001979_bb0095
  article-title: Cubilin, a high-density lipoprotein receptor
  publication-title: Curr Opin Lipidol
  doi: 10.1097/00041433-200004000-00005
  contributor:
    fullname: Moestrup
– volume: 124
  start-page: 187
  year: 1982
  ident: 10.1038/sj.ki.5001979_bb0125
  article-title: Plasma LCAT activities in renal allograft recipients
  publication-title: Clin Chim Acta
  doi: 10.1016/0009-8981(82)90386-2
  contributor:
    fullname: Chan
– volume: 11
  start-page: 105
  year: 2000
  ident: 10.1038/sj.ki.5001979_bb0140
  article-title: Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V111105
  contributor:
    fullname: Kronenberg
– volume: 61
  start-page: 1887
  year: 2002
  ident: 10.1038/sj.ki.5001979_bb0020
  article-title: Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2002.00324.x
  contributor:
    fullname: Iseki
– volume: 9
  start-page: 1277
  year: 1998
  ident: 10.1038/sj.ki.5001979_bb0055
  article-title: Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V971277
  contributor:
    fullname: Shoji
– volume: 12
  start-page: 2603
  year: 1997
  ident: 10.1038/sj.ki.5001979_bb0060
  article-title: Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/12.12.2603
  contributor:
    fullname: Koch
– volume: 10
  start-page: CR439
  year: 2004
  ident: 10.1038/sj.ki.5001979_bb0120
  article-title: Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study
  publication-title: Med Sci Monit
  contributor:
    fullname: Mekki
– volume: 13
  start-page: 194
  year: 2003
  ident: 10.1038/sj.ki.5001979_bb0130
  article-title: Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/S0939-4753(03)80011-X
  contributor:
    fullname: Espino-Montoro
– volume: 16
  start-page: 1794
  year: 2005
  ident: 10.1038/sj.ki.5001979_bb0155
  article-title: High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2004110922
  contributor:
    fullname: Longenecker
– volume: 14
  start-page: 732
  year: 2003
  ident: 10.1038/sj.ki.5001979_bb0045
  article-title: LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000046962.43220.8A
  contributor:
    fullname: Miida
– volume: 9
  start-page: 1474
  year: 1998
  ident: 10.1038/sj.ki.5001979_bb0145
  article-title: Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V981474
  contributor:
    fullname: De Sain-Van Der Velden
– volume: 111
  start-page: 677
  year: 1988
  ident: 10.1038/sj.ki.5001979_bb0115
  article-title: Defect in cholesteryl ester transport in serum of patients with uremia receiving maintenance hemodialysis: increased inhibitor activity for cholesteryl ester transfer
  publication-title: J Lab Clin Med
  contributor:
    fullname: Mendez
– volume: 145
  start-page: 227
  year: 1999
  ident: 10.1038/sj.ki.5001979_bb0110
  article-title: Remodelling of high density lipoproteins by plasma factors
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(99)00150-1
  contributor:
    fullname: Rye
– volume: 45
  start-page: 275
  year: 2005
  ident: 10.1038/sj.ki.5001979_bb0070
  article-title: Insulin resistance in patients with chronic kidney disease
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2004.09.034
  contributor:
    fullname: Kobayashi
– volume: 16
  start-page: 237
  year: 2000
  ident: 10.1038/sj.ki.5001979_bb0085
  article-title: Related Reverse cholesterol transport in diabetes mellitus
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/1520-7560(200007/08)16:4<237::AID-DMRR127>3.0.CO;2-9
  contributor:
    fullname: Quintao
– volume: 351
  start-page: 1296
  year: 2004
  ident: 10.1038/sj.ki.5001979_bb0015
  article-title: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa041031
  contributor:
    fullname: Go
– volume: 77
  start-page: 139
  year: 1989
  ident: 10.1038/sj.ki.5001979_bb0135
  article-title: Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration
  publication-title: Atherosclerosis
  doi: 10.1016/0021-9150(89)90075-0
  contributor:
    fullname: Malmendier
SSID ssj0008930
Score 2.0689147
Snippet Cardiovascular risk increases with each decrement in renal function. Abnormalities in plasma lipoprotein composition among patients with end-stage renal...
SourceID proquest
crossref
nature
elsevier
SourceType Aggregation Database
Publisher
StartPage S55
SubjectTerms apo A I
apo C III
CETP
hepatic lipase
IDL
LCAT
SummonAdditionalLinks – databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT8IwFG4UEuPF-IuIqOnBeCt0azc2L0QRQkwgxkjCrdleuwRIBjo48N_bbt3UA55ftsNb-32v-16_h9B9kGhSckOP-ExKwkM_IrEru4QqFvuUg0dzRXc88UdT_jrzZrY3J7NtlSUm5kAtV2D-kXdcc8wMqUd7609ihkYZcdVO0DhEddfhRqWtPw8mb-8VFGsyLu6gBB5x9da2JpuUBZ1s0V7O254pcUwb1x5S-uOu-YPTOfkMT9GJrRrxU_GZz9CBSs_R0djq4heo97LT9WIx7DXC8xRD4XmLl3OZqh22Mswj7kfbTGU4SiWGX33Ul2g6HHz0R8SORiDAumxDFI8SfXACiEH50u9ycz_WizxHSa5JWYVKJg6EgQ8MeJJIkGCs2lTCgUU6whqolq5SdYUwOC5lLOSxC8BNUwwwFdIkkMbZPQlUEz2UuRHrwgFD5Mo1C0S2EMu5sElsIlpmTlj6LmhZaHTe90ijyHD15irQKjMu7KbKRLUErv-NttCxa6cLUecG1TZfW3WrK4dNfGfXxzeDwcIq
  priority: 102
  providerName: ProQuest
Title Dyslipidemia in chronic kidney disease: Causes and consequences
URI https://dx.doi.org/10.1038/sj.ki.5001979
http://dx.doi.org/10.1038/sj.ki.5001979
https://www.proquest.com/docview/210169050
Volume 70
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3PT8IwFG4QEuPF-DMianow3gZlbffDiwGEEBU0Rg3x0myvXTJIJnFw4L-33QrqwYOnJmu6Ld_W7732vfcVocsg0UbJDbnjUSkdFnqRE7vSd4iisUcYcFJEdEdjb_jK7iZ8UkG9dS2MSau03F9yesHW9krLotmap2lR48tdPV8LUTEe6nV7zTVhpiqqdbpv9w8bQtYmuaxECbhjBlipTUKDVj5tztImN46OSeb6wzT90tj8ZuvCBA320K71HXGnfL19VFHZAdoe2ej4Ibq5XWmvsTzyNcJphqFUvsWzVGZqhW0w5hr3omWuchxlEsOPbOoj9Drov_SGjj0gwQHq04WjWJTo5RNADMqTns9MlSyPeFtJpk2zCpVM2hAGHlBgSSJBghFsUwkDGukeeoyq2UemThCGtksoDVnsAjCTGgNUhSQJpNF3TwJVR1drbMS81MEQRfyaBiKfilkqLIh1RNbIiV8fUmiO_mvIcYnw5s6bjsYacWGnVi5cs98QEk5O__-kBtpx7cFDpH2GqovPpTrXTsUivkBb_sS_sL-Obrv98dOzbse9yeP7F8u8zkk
link.rule.ids 315,786,790,12083,21416,27600,27955,27956,31752,33777,43343,43838,45696
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT8JAEN0oJurF-EVE_NiD8bawdLel9UIMSlCBEyTcNu3sNgGSghYO_Ht3223VA54n7eF1dt5MZ_YNQg9-rEnJCVziMSkJD7yQRI5sE6pY5FEOLs06usOR15_w96k7tbM5qR2rLGJiFqjlEsw_8qZjysyAurSz-iRmaZRprtoNGvvogDPGjZu3p2W9RTUV5zdQfJc4-mBbiU3K_GY6byxmDdckOGaIawcl_dHW_InSGfX0TtGJzRnxc_6Rz9CeSs7R4dB2xS9Q52Wrs8V81WuIZwmGXPEWL2YyUVtsmzBPuBtuUpXiMJEYfk1RX6JJ73Xc7RO7GIEAa7M1UTyMddkEEIHypNfm5nasG7otJbmmZBUoGbcg8D1gwONYggQj1KZiDizUFlZFlWSZqCuEoeVQxgIeOQDcjMQAUwGNfWl03WNf1dBjgY1Y5foXIutbM1-kc7GYCQtiDdECOWHJOydloWPzrkeqOcLlm0tDvUBc2COVitIBrv-13qOj_ng4EIO30UcdHTt2zxBt3aDK-mujbnUOsY7uMk_5Bm3bw7E
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dyslipidemia+in+chronic+kidney+disease%3A+Causes+and+consequences&rft.jtitle=Kidney+international&rft.au=Kaysen%2C+G.A.&rft.date=2006-12-01&rft.issn=0085-2538&rft.volume=70&rft.spage=S55&rft.epage=S58&rft_id=info:doi/10.1038%2Fsj.ki.5001979&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_sj_ki_5001979
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0085-2538&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0085-2538&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0085-2538&client=summon